Date,Title,Link,Status,Source
"""Nov 28, 2017""","""Cramer's lightning round: Don't be greedy, buy Celgene\u00a0here""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.cnbc.com/2017/11/28/cramers-lightning-round-dont-be-greedy-buy-celgene-here.html&cid=52779695612456&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFiOhLhYlyIPge-1x6q-qeIM3DhuQ""",1,"""CNBC"""
"""Nov 20, 2017""","""Celgene Corporation Stock Is a Steal Right Now, Here's\u00a0Why""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/celg-stock-steal-now/&cid=52779683441914&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNHUwk8lryubajXAOfDsMYD9o86K_w""",2,"""Investorplace.com"""
"""Nov 16, 2017""","""Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171116005818/en/Celgene-Corporation-bluebird-bio-Announce-bb2121-Anti-BCMA&cid=52779678569497&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFnr3pSZ-n11Ci-03zHkkoXQM3Wsw""",3,"""Business Wire (press release)"""
"""Nov 10, 2017""","""Stocks In The Dog House:\u00a0Celgene""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://seekingalpha.com/article/4123326-stocks-dog-house-celgene&cid=52779665326071&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGOr7J_U0VEqF2y1HvFL5BZ7q4gyg""",Not Reachable,"""Seeking Alpha"""
"""Nov 28, 2017""","""Why Is Celgene (CELG) Up 3.4% Since the Last Earnings\u00a0Report?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/why-is-celgene-celg-up-34-since-the-last-earnings-report-cm882930&cid=52779693023259&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGS11LIPHbZF6nZyMuMvbAUmK2tLQ""",4,"""Nasdaq"""
"""Nov 21, 2017""","""Celgene Corporation to Webcast an Analyst and Investor Event from the American\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171121005478/en/Celgene-Corporation-Webcast-Analyst-Investor-Event-American&cid=0&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNEEiyvr5K4_DDh8Bi6bf1okF7QVYw""",5,"""Business Wire (press release)"""
"""Nov 17, 2017""","""Trade of the Day: Celgene Corporation Attempts a\u00a0Breakout""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/trade-day-celgene-corporation-celg-stock-attempts/&cid=52779678827429&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFnorNZEX1aUGiyLbY7CX7QyGZMSw""",6,"""Investorplace.com"""
"""Oct 31, 2017""","""Celgene Q3 2017: Not Far From Zero Pipeline\u00a0Value""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://seekingalpha.com/article/4118549-celgene-q3-2017-far-zero-pipeline-value&cid=52779654957650&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNH1Vh1X1LM3gamDKqVuX9Mbd4Xrkw""",7,"""Seeking Alpha"""
"""2 hours ago""","""Celgene Corporation (CELG) Holdings Increased by Marathon Capital\u00a0Management""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/30/marathon-capital-management-acquires-1075-shares-of-celgene-corporation-celg.html&cid=52779692412201&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNH2MVHqTlWIK-MADYA5-yYjWMbs0A""",Not Reachable,"""The Ledger Gazette"""
"""Nov 1, 2017""","""Celgene's Gilead\u00a0Moment""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://seekingalpha.com/article/4118983-celgenes-gilead-moment&cid=0&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFWiAmGsUyYnWF65P6n_vhhi2IN7w""",Not Reachable,"""Seeking Alpha"""
"""Nov 2, 2017""","""Sharp Drop Celgene Corporation Stock May Have Just Created an Entry\u00a0Point""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/celgene-corporation-stock-may-have-just-created-an-entry-point/&cid=52779658305435&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNHMQkTngWg-_-cfiJ68OAMoRX4JEw""",8,"""Investorplace.com"""
"""18 hours ago""","""Lightning Round: Jim Cramer Shares His Thoughts On Celgene, ON Semiconductor\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.benzinga.com/media/cnbc/17/11/10843386/lightning-round-jim-cramer-shares-his-thoughts-on-celgene-on-semiconductor&cid=52779696262906&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGoP74oM-IjvDwIgBRNt32iQHv-ow""",9,"""Benzinga"""
"""14 hours ago""","""Celgene Corporation (CELG) \u2013 Technical\u00a0observation""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/29/celgene-corporation-celg-technical-observation/&cid=52779693379498&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNF84mCfm-YSNRKVCDzW2ZpL9dlRQA""",10,"""Stocks Gallery"""
"""Nov 14, 2017""","""Taking a Fresh Look at Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://stocknewsjournal.com/2017/11/14/taking-a-fresh-look-at-celgene-corporation-celg-5/&cid=52779675303103&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFRLgaTBzAQ9sS83PgMc2Ns9Sfscw""",11,"""StockNewsJournal"""
"""15 hours ago""","""A Preview of Valuations Summary: Taiwan Semiconductor Manufacturing Company\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://postanalyst.com/2017/11/29/a-preview-of-valuations-summary-taiwan-semiconductor-manufacturing-company-limited-tsm-celgene-corporation-celg/&cid=52779695836607&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFCi2rqABHOR7_D7L_q_uJisQfFSA""",12,"""Post Analyst"""
"""17 hours ago""","""Celgene Corporation (CELG) moves -29.34% away from 52-Week High = Technical\u00a0Facts""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.analystsbuzz.com/2017/11/29/celgene-corporation-celg-moves-29-34-away-from-52-week-high-technical-facts/&cid=52779695557472&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNF6FxZDxOhhxUjMCzAZDSkoR19vXg""",13,"""Voice Of Analysts"""
"""Nov 27, 2017""","""Reading the Tea Leaves for Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://economicsandmoney.com/2017/11/27/reading-the-tea-leaves-for-celgene-corporation-celg/&cid=52779695389528&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNF77vihH80ISdbSDgX7n9q-2qbNLA""",14,"""Economic News"""
"""12 hours ago""","""Analyzing the Insider Data for Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.nystocknews.com/2017/11/29/analyzing-the-insider-data-for-celgene-corporation-celg-3/&cid=52779696853007&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFaPmAPn-VIRXAn43E60p912dGwRw""",15,"""NY Stock News"""
"""Nov 7, 2017""","""The Stumbling Blocks Of Celgene-Dependent Acceleron And Why You Should Hedge\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://seekingalpha.com/article/4121613-stumbling-blocks-celgene-dependent-acceleron-hedge-bets&cid=52779665947825&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNHjG2Mq6vPaMrNG0dIy-1wMgLLNrQ""",Not Reachable,"""Seeking Alpha"""
"""Nov 1, 2017""","""Celgene Prices $3 Billion of Senior Unsecured\u00a0Notes""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171101005855/en/Celgene-Prices-3-Billion-Senior-Unsecured-Notes&cid=52779658874951&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNEtGioN0WxdmUydCiJSHnzUhH7J6w""",16,"""Business Wire (press release)"""
"""Nov 8, 2017""","""Due To Its Strong Growth Potential, Celgene Is Undervalued Right\u00a0Now""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://seekingalpha.com/article/4122405-due-strong-growth-potential-celgene-undervalued-right-now&cid=52779667266301&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFc4eTF-q867cdvZACN3IM0yGTkQw""",Not Reachable,"""Seeking Alpha"""
"""Nov 27, 2017""","""Heading Towards a Potential Reversal? Celgene Corporation (CELG), Glu Mobile\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://financialqz.com/2017/11/27/heading-towards-a-potential-reversal-celgene-corporation-celg-glu-mobile-inc-gluu/&cid=52779691656637&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFpc0mGy3tZqSMMRq-FhDg6dcQKhg""",17,"""Market Movers"""
"""Nov 3, 2017""","""Why Celgene Crashed 30% in October -- and What\u00a0Now?""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.fool.com/investing/2017/11/03/why-celgene-crashed-30-in-october-and-what-now.aspx&cid=52779662124896&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFWzC8-glmCknav9pkdLPV1UuSljA""",18,"""Motley Fool"""
"""14 hours ago""","""Celgene Corporation (CELG)- Stocks under Performance\u00a0Radar""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://nasdaqtimes.com/celgene-corporation-celg-stocks-under-performance-radar/&cid=52779686264094&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNELHgYJzCpyWtUD5BX-ej8ESQp0OQ""",19,"""NASDAQ Times"""
"""10 hours ago""","""Celgene Corporation (NASDAQ:CELG) \u2013 Is The Stock Overvalued? (P/E\u00a0Analysis)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://nasdaqjournal.com/index.php/2017/11/29/celgene-corporation-nasdaqcelg-is-the-stock-overvalued-p-e-analysis/&cid=52779696379998&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGTA1n_1U8DTzE7x4lKglYThNx7Qg""",20,"""Nasdaq Journal (press release)"""
"""Nov 22, 2017""","""Delve into today's share market: Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://news4j.com/2017/11/22/delve-into-todays-share-market-celgene-corporation-celg/&cid=52779685588181&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGG6PnLoE95cHemVQlwqp3jnxL9xw""",21,"""The News Journal"""
"""Nov 21, 2017""","""Results from 282 Abstracts Including Celgene Therapies and Pipeline Compounds\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171121005493/en/Results-282-Abstracts-Including-Celgene-Therapies-Pipeline&cid=52779684998863&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNEdVfNtvynm7tlc1GWkZM7aKyXqBQ""",22,"""Business Wire (press release)"""
"""15 hours ago""","""Celgene Corporation (CELG) P/E 24.50 shows that the company is worth\u00a0more""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.streetobserver.com/2017/11/29/celgene-corporation-celg-p-e-24-50-shows-that-the-company-is-worth-more/&cid=52779696136152&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFsu8K4-dZs9CBFQmy9_JTLJKBKwQ""",23,"""Street Observer (press release)"""
"""Nov 26, 2017""","""Celgene Corporation (CELG) Given New $155.00 Price Target at BMO Capital\u00a0Markets""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://ledgergazette.com/2017/11/26/bmo-capital-markets-raises-celgene-corporation-celg-price-target-to-155-00.html&cid=52779685622660&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNG8xzlPQ9u-pp8Dqs-F8V4cGGPEoA""",Not Reachable,"""The Ledger Gazette"""
"""Nov 27, 2017""","""Comparable Company Analysis: Celgene Corporation (CELG), Spirit AeroSystems\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://allstocknews.com/2017/11/27/comparable-company-analysis-celgene-corporation-celg-spirit-aerosystems-holdings-inc-spr/&cid=52779687594729&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNE8YZTCGFsQqTBOxTL6kRovnENY-w""",24,"""AllStockNews"""
"""Nov 27, 2017""","""Celgene (CELG) a Sell on Slumping Quant\u00a0Score""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://investorplace.com/2017/11/celgene-celg-a-sell-on-slumping-quant-score/&cid=52779694015020&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNEbRP6uY8Rs6tl3N-7n7iz_57uceQ""",25,"""Investorplace.com"""
"""Oct 31, 2017""","""Celgene Announces Offering of Senior Unsecured\u00a0Notes""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.businesswire.com/news/home/20171031005826/en/Celgene-Announces-Offering-Senior-Unsecured-Notes&cid=52779657653249&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNEUNQTCQIaTT6j2bsbMzm4Cy2j6bw""",26,"""Business Wire (press release)"""
"""Nov 27, 2017""","""Your Daily Pharma Scoop: Celgene's Upside, Regeneron Setback, AstraZeneca\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://seekingalpha.com/article/4127791-daily-pharma-scoop-celgenes-upside-regeneron-setback-astrazeneca-submits-snda-japan&cid=0&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNECSSh9loRfRcv6pNAcm4Fl30dswA""",Not Reachable,"""Seeking Alpha"""
"""Nov 17, 2017""","""Stocks that beat the best in todays market: Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://news4j.com/2017/11/16/stocks-that-beat-the-best-in-todays-market-celgene-corporation-celg/&cid=52779676712623&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNE-Rk-hDMb3ZI_6TisaXa0j6o4NjQ""",27,"""The News Journal"""
"""Nov 17, 2017""","""Buy or Sell? What Analysts Recommends: Celgene Corporation (CELG), New York\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/17/buy-or-sell-what-analysts-recommends-celgene-corporation-celg-new-york-reit-inc-nyrt/&cid=52779679848531&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGhjUexNJHmpeHU69PhVaZSK7DA-g""",28,"""StockNewsJournal"""
"""Nov 8, 2017""","""Today Analysts Focus on Hewlett Packard Enterprise Company (HPE), Celgene\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.stocknewsjournal.com/2017/11/08/today-analysts-focus-on-hewlett-packard-enterprise-company-hpe-celgene-corporation-celg/&cid=52779666704257&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNEaWqOiALPKs9QFoi7_6ihrRHiMuQ""",29,"""StockNewsJournal"""
"""17 hours ago""","""What Market views are telling to dormant Shareholders?: Celgene Corporation\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/29/what-market-views-are-telling-to-dormant-shareholders-celgene-corporation-nasdaq-celg-cognex-corporation-nasdaq-cgnx-ggp-inc-nyse-ggp-twilio-inc-nyse-twlo/&cid=52779695540526&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNHx0SVbHSaFVhve3p921-LzNCF0QQ""",30,"""Stocks In The News (press release)"""
"""17 hours ago""","""Stock Survey: Checking Levels for Celgene Corporation\u00a0(NasdaqGS:CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://finnewsweek.com/stock-survey-checking-levels-for-celgene-corporation-nasdaqgscelg/561292/&cid=52779697185086&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNFGVi1NlzIRLE7Ybr9Ouz5mUhW9qg""",31,"""Financial Newsweek"""
"""Nov 27, 2017""","""Snapshot of Recent Traded Stock Celgene Corporation (CELG) -17.00% off from\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.analystsbuzz.com/2017/11/27/snapshot-of-recent-traded-stock-celgene-corporation-celg-17-00-off-from-200-sma/&cid=52779694803435&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNGgvUXf_tCwazuN77jBwQ8bKHw4dA""",32,"""Voice Of Analysts"""
"""16 hours ago""","""Celgene Corporation (NASDAQ: CELG) \u2013 Attention Seeking\u00a0Stock""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://alphabetastock.com/celgene-corporation-nasdaq-celg-attention-seeking-stock/&cid=52779691579183&ei=iK4fWsHeH4TZjAHpqpfYCw&usg=AFQjCNHKZnYii0U0StArwJa6-sZg2RcH4g""",33,"""Alpha Beta Stock"""
"""16 hours ago""","""Celgene Corporation (NASDAQ: CELG) \u2013 Attention Seeking\u00a0Stock""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://alphabetastock.com/celgene-corporation-nasdaq-celg-attention-seeking-stock/&cid=52779691579183&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGOnbqOR4G_ZKFKDDz-05asJnFrUw""",34,"""Alpha Beta Stock"""
"""11 hours ago""","""Alluring Stocks- Celgene Corporation (NASDAQ:CELG) a Biotechnology\u00a0Company""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.thestreetpoint.com/2017/11/29/alluring-stocks-celgene-corporation-nasdaqcelg-a-biotechnology-company/&cid=52779690764178&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGwy-X2CDrQTH2yC0JRemEtIrm05w""",35,"""The Stock Street (press release)"""
"""Nov 12, 2017""","""3 Top Biotech Stocks for\u00a02018""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.fool.com/investing/2017/11/12/3-top-biotech-stocks-for-2018.aspx&cid=52779673319923&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFFY8Nudi2xBKomWh76LoQwbHrvag""",36,"""Motley Fool"""
"""Nov 28, 2017""","""Celgene Corporation (CELG) registers a price change of -1.12% while Organovo\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stocksgallery.com/2017/11/28/celgene-corporation-celg-registers-a-price-change-of-1-12-while-organovo-holdings-inc-onvo-finishes-with-a-flow-of-0-66/&cid=0&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFrxQ0i2uALdGq-uvV8R5EVuMNP0Q""",37,"""Stocks Gallery"""
"""Nov 10, 2017""","""Marvin & Palmer Associates Inc Buys Celgene Corp, PayPal Holdings Inc, Adobe\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.nasdaq.com/article/marvin-palmer-associates-inc-buys-celgene-corp-paypal-holdings-inc-adobe-systems-inc-cm875683&cid=0&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFiQEoe-exvnNlsAkJwhPkXq94HCg""",38,"""Nasdaq"""
"""16 hours ago""","""Celgene Corporation (CELG) Needs Strong Boost to Get Active Moment in\u00a0Street""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stockmarketstop.com/celgene-corporation-celg-needs-strong-boost-to-get-active-moment-in-street/875513/&cid=52779694850411&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGZd9YkzknshosP6YmY3igStqnZxw""",39,"""Stock News Stop"""
"""20 hours ago""","""Analysts Watch-List Stock: Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.wallstreetmorning.com/2017/11/29/analysts-watch-list-stock-celgene-corporation-celg/&cid=52779694019344&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNG7gjniQJNfsr22PwoUiAml51WPXg""",40,"""Wall Street Morning"""
"""Nov 10, 2017""","""Shares to buy from the think tanks: Celgene Corporation\u00a0(NASDAQ:CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://news4j.com/2017/11/10/shares-to-buy-from-the-think-tanks-celgene-corporation-nasdaqcelg/&cid=52779669641559&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFA69jA7eUF7wmZ2lWvkw165yJoOg""",41,"""The News Journal"""
"""Nov 28, 2017""","""Market seeker stock\u2013 Celgene Corporation (NASDAQ:CELG) a Biotechnology\u00a0Company""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.thestreetpoint.com/2017/11/28/market-seeker-stock-celgene-corporation-nasdaqcelg-a-biotechnology-company/&cid=52779694150022&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGsAc-ucEwxXgNEmW0Hf2wkzcdqeg""",42,"""The Stock Street (press release)"""
"""15 hours ago""","""Market Chatter: Following the Levels for Celgene Corporation\u00a0(NASDAQ:CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://mtnvnews.com/market-chatter-following-the-levels-for-celgene-corporation-nasdaqcelg/357542/&cid=52779695468544&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNHISrGeiuQRyGTkFYKTbI2C8ARf0A""",43,"""MTNV"""
"""Nov 27, 2017""","""How Technical Charts Are Flashing For Pure Storage, Inc. (PSTG), Celgene\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.postanalyst.com/2017/11/27/how-technical-charts-are-flashing-for-pure-storage-inc-pstg-celgene-corporation-celg/&cid=52779692478158&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGU_regrcj9jgSO4HloOW2mFn8bFQ""",44,"""Post Analyst"""
"""Nov 27, 2017""","""Buy the position in Healthcare Stock: Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.streetobserver.com/2017/11/27/buy-the-position-in-healthcare-stock-celgene-corporation-celg/&cid=52779690830501&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFXh19r7GKaSFfMe_VreQyQkFlgLg""",45,"""Street Observer (press release)"""
"""Nov 28, 2017""","""Use of charts to make investment decisions about Celgene Corporation\u00a0(CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.wallstreetmorning.com/2017/11/28/use-of-charts-to-make-investment-decisions-about-celgene-corporation-celg-2/&cid=52779690995323&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNHorljdjv77-ax7ypaHbPkPN86Wlw""",46,"""Wall Street Morning"""
"""16 hours ago""","""Volatile Stock to Watch \u2013 Celgene Corporation (NASDAQ:\u00a0CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.hotstockspoint.com/2017/11/volatile-stock-to-watch-celgene-corporation-nasdaq-celg/&cid=52779696181012&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNE1WhiXRDE8y7OqIAQexPCS-FZfKg""",47,"""Hot Stocks Point"""
"""Nov 27, 2017""","""Hot Stock Evaluation \u2013 Celgene Corporation (NASDAQ:\u00a0CELG)""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.hotstockspoint.com/2017/11/hot-stock-evaluation-celgene-corporation-nasdaq-celg-2/&cid=52779691744143&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNENzF93HQh1ui6Eb6C7Wy3dI9CKZA""",48,"""Hot Stocks Point"""
"""Nov 27, 2017""","""A New Kind of Stock Chart: Celgene Corporation (NASDAQ:CELG) Critical Pivot\u00a0Points""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://news.cmlviz.com/2017/11/27/a-new-kind-of-stock-chart-celgene-corporation-nasdaq-celg--critical-pivot-points.html&cid=52779691890097&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNG1eXPOWC9EVnScpRV1bMtnwf4pFw""",49,"""CML News"""
"""6 hours ago""","""Forget Penny Stocks, Your Money Is Better Off in These 3\u00a0Companies""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.fool.com/investing/2017/11/29/forget-penny-stocks-your-money-is-better-off-in-th.aspx&cid=52779697094894&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGKlaxozg_3RXTJrHepbKrcb_uNUw""",50,"""Motley Fool"""
"""Nov 24, 2017""","""Stock Volatility Risk Alert: Celgene Corporation Realized Volatility Hits An\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://news.cmlviz.com/2017/11/24/stock-volatility-risk-alert-celgene-corporation-realized-volatility-hits-an-exceptional-high.html&cid=52779689089387&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNE2jNSKfQg4DvV4Xod34sDbcItmdQ""",51,"""CML News"""
"""6 hours ago""","""Celgene Corp (CELG) AO Seeing a Consistent Trend\u00a0Higher""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.concordregister.com/celgene-corp-celg-ao-seeing-a-consistent-trend-higher/&cid=52779695185607&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNHXKnCB2MmsTTklml6fYc5YHurUNQ""",52,"""Concord Register"""
"""14 hours ago""","""Celgene Corp (CELG) Needle Moving\u00a00.52%""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://earlebusinessunion.com/celgene-corp-celg-needle-moving-0-52/460178/&cid=52779697396653&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGDgC3XY3uTb_s54-YJxefsoaYKrA""",53,"""The Business Union"""
"""12 hours ago""","""Outshines Stocks with Rosy Profitability: Celgene Corporation (NASDAQ:CELG\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.senecaglobe.com/outshines-stocks-with-rosy-profitability-celgene-corporation-nasdaqcelg-sorl-auto-parts-inc-nasdaqsorl/385537/&cid=52779696264327&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNH2t-HLqlKSCHtyDVmU_c9qkfrB9g""",54,"""Seneca Globe"""
"""Nov 28, 2017""","""Keeps Strong Position in Short-Range Obligations: Celgene Corporation (NASDAQ\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.stockmarketstop.com/keeps-strong-position-in-short-range-obligations-celgene-corporation-nasdaqcelg/874898/&cid=52779690845558&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNHGB1FVbNKR_SrDKEpgvnhNJvFVTQ""",55,"""Stock News Stop"""
"""Nov 27, 2017""","""Celgene Corporation, (NASDAQ: CELG), Itau Unibanco Holding SA, (NYSE: ITUB\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://www.tradingnewsnow.com/2017/11/27/celgene-corporation-nasdaq-celg-itau-unibanco-holding-s-a-nyse-itub-the-estee-lauder-companies-inc-nyse-el-acco-brands-corporation-nyse-acco-revenue-approximations-analysis/&cid=52779690919787&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGW_s9TFKU-dEy7yQ74aAlL2uAW3w""",56,"""Stocks In The News (press release)"""
"""Nov 28, 2017""","""All The Recent Sell-Side Sentiment On Hanesbrands Inc. (HBI) and Celgene\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://usacommercedaily.com/2017/11/28/all-the-recent-sell-side-sentiment-on-hanesbrands-inc-hbi-and-celgene-corporation-celg/&cid=52779691640572&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNGGfJgdGZRBjs0KZ3MTCmjlYywydA""",57,"""USA Commerce Daily"""
"""13 hours ago""","""Drug Charity May Shutter After US Faults Pharma\u00a0Influence""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.bloomberg.com/news/articles/2017-11-29/pharma-charity-may-shut-after-u-s-faults-drugmakers-influence&cid=52779696620074&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFKP-Cpn-oQQq2OFj7juHOlsA7JbA""",58,"""Bloomberg"""
"""17 hours ago""","""Placing These Stocks in the Hotbed: Celgene Corporation (NASDAQ:CELG) and HDFC\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://morganleader.com/placing-these-stocks-in-the-hotbed-celgene-corporation-nasdaqcelg-and-hdfc-bank-limited-nysehdb/&cid=0&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFnnNsRRYo0zLVHG3tVWWh1a0liRg""",59,"""Morgan Research"""
"""Nov 28, 2017""","""Celgene Corporation (CELG) In Active Momentum Stocks on Ration Analysis- Tile\u00a0...""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://www.investingbizz.com/2017/11/celgene-corporation-celg-in-active-momentum-stocks-on-ration-analysis-tile-shop-holdings-inc-tts/&cid=52779695735282&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNEAAWyXP75gutQjqH5yaa67PA5CTA""",60,"""Investing News Update"""
"""Nov 28, 2017""","""Celgene Corporation (NasdaqGS:CELG): A Look at the Stock's\u00a0F-Score""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=http://rockvilleregister.com/celgene-corporation-nasdaqgscelg-a-look-at-the-stocks-f-score/552457/&cid=52779696600843&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNF77j9dDq0y0EDkPaE9jQM8te68KQ""",61,"""Rockville Register"""
"""19 hours ago""","""CELGENE CORP. DL-01 (CG3.DE): Tracking the\u00a0Indicators""","""http://news.google.com/news/url?sa=T&ct2=us&fd=S&url=https://haydenbusinessjournal.com/celgene-corp-dl-01-cg3-de-tracking-the-indicators/300112/&cid=52779697075054&ei=UK8fWsGsBtTa2AaJ143ABw&usg=AFQjCNFFbPww3HlWTu_1CAKHyAncBdBtzA""",62,"""Hayden Business Journal"""
"""Nov 16, 2017""","""Celgene Corp and bluebird bio announce bb2121 anti-BCMA CAR-T cell therapy has been granted Breakthrough Therapy designation from\u00a0FDA""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3715608&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNHE3i6t0_lGwcjPpbtpkQTTObjpRQ""",Not Reachable,"""Reuters Key Development"""
"""Nov 1, 2017""","""Celgene prices $3 billion of senior unsecured\u00a0notes""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3701180&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNGXZazRMotZOMddZ6W1dxCOTzl_LQ""",Not Reachable,"""Reuters Key Development"""
"""Oct 31, 2017""","""Celgene announces offering of senior unsecured\u00a0notes""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3700156&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNFlm5FN8PFGWnHJzO2dJZtImVEVYw""",Not Reachable,"""Reuters Key Development"""
"""Oct 30, 2017""","""Lannett and Celgene enter into settlement and license agreement related to\u00a0Thalomid""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3698439&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNGfHWWPicJR5KqL-OhaN0sZcHGxsA""",Not Reachable,"""Reuters Key Development"""
"""Oct 26, 2017""","""Celgene Corp updates on court order at request of Canadian Competition Bureau - SEC\u00a0filing""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3696133&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNETmrwurT2Z-0BtkYSLXNYnCbSWIw""",Not Reachable,"""Reuters Key Development"""
"""Oct 26, 2017""","""Celgene initiating share repurchase\u00a0plan""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3695889&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNEN4UGeycP5o4nrvavJxlsk8i7KjA""",Not Reachable,"""Reuters Key Development"""
"""Oct 26, 2017""","""Celgene reports Q3 earnings per share of\u00a0$1.21""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3695678&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNGmSSdRJT4vp5Z0JxUUuqpzOy7daA""",Not Reachable,"""Reuters Key Development"""
"""Oct 19, 2017""","""Celgene says net pre-tax charge to Q4 earnings estimated to be $300 mln to $500\u00a0mln""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3690521&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNHTouh89lLfYO-ZIH7LmGbNs5V6CQ""",Not Reachable,"""Reuters Key Development"""
"""Oct 19, 2017""","""Celgene provides update on GED-0301 (mongersen) inflammatory bowel disease\u00a0program""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3690486&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNGS6JwJlTpMneXEXUto4VcQeei_2A""",Not Reachable,"""Reuters Key Development"""
"""Oct 3, 2017""","""Celgene and Nimbus Therapeutics enter long-term strategic immunology alliance to develop programs for patients with autoimmune\u00a0disorders""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3681827&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNE0DUnijrEaNwPz6D5mUcsX0oUkCA""",Not Reachable,"""Reuters Key Development"""
"""Sep 19, 2017""","""Acceleron Pharma says entered into an agreement with Celgene\u00a0Corp""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3674493&ei=t68fWriNLcS6jAHwso7gBA&usg=AFQjCNEX5PZsITTRPuRvgTTApMuUUit9iA""",Not Reachable,"""Reuters Key Development"""
"""Sep 11, 2017""","""Alvogen unit confirms ANDA filing and patent challenge for generic\u00a0Revlimid""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3670379&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFMhQP5H0GqDhrcqYR72CJAmHh-sw""",Not Reachable,"""Reuters Key Development"""
"""Sep 7, 2017""","""Celgene provides update on the Fusion clinical\u00a0program""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3668840&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGW4ujIrdMXPH0v0RDQn7MPHXZuhg""",Not Reachable,"""Reuters Key Development"""
"""Sep 1, 2017""","""Celgene Corp reports 5.6 percent passive stake in BeiGene as of Aug 31 - SEC\u00a0filing""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3666236&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEFcfotgo3nZB-TjuFJHJ_2DEESMg""",Not Reachable,"""Reuters Key Development"""
"""Aug 10, 2017""","""Celgene Corp says on August 10, co issued $500 million aggregate principal amount of 2.250% senior notes due\u00a02021""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3650013&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHI2AuuIVtGU-IbujixYktMsOa_6Q""",Not Reachable,"""Reuters Key Development"""
"""Jul 6, 2017""","""Celgene enters collaboration with BeiGene to advance inhibitor program for solid tumor\u00a0cancers""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3623398&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHn7KMNDK_MQBUHx_y76kV4o9Fx6w""",Not Reachable,"""Reuters Key Development"""
"""Jun 14, 2017""","""Celgene International S\u00ef\u00bf\u00bdrl announces results from phase 2a SLE-001 trial evaluating\u00a0CC-220""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3612009&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHoS7gQJ61bMs3xPbOM6wMe7X5g2A""",Not Reachable,"""Reuters Key Development"""
"""Jun 6, 2017""","""Agios Pharmaceuticals says IDHIFA NDA given PDUFA action date of Aug.\u00a030""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3607638&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHn_gC-FwgjyZ1jySESL-HoDYaQig""",Not Reachable,"""Reuters Key Development"""
"""Jun 1, 2017""","""Celgene and Acceleron complete enrollment in MEDALIST, BELIEVE Phase 3 studies of\u00a0luspatercept""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3605290&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFoaZ_yyZCPpNsuyaunzWuTwf7KgA""",Not Reachable,"""Reuters Key Development"""
"""May 22, 2017""","""Celgene announces positive results from\u00a0radiance""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3598422&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGtOX3BblzO1Z6uZfw2N31MBgrdjA""",Not Reachable,"""Reuters Key Development"""
"""Apr 13, 2017""","""Diplomat Pharmacy on March 31,co, units, Celgene entered into pharmacy distribution, services agreement to be effective July 1,\u00a02017""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3568042&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNH5NIYAxF7D1Xknyo_l-CtKT5pJAA""",Not Reachable,"""Reuters Key Development"""
"""Mar 20, 2017""","""Cipher Pharmaceuticals appoints Robert Tessarolo as\u00a0CEO""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3551130&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHneHKjFMTBNt-Cs6DCvWp4f128nA""",Not Reachable,"""Reuters Key Development"""
"""Mar 15, 2017""","""Alliqua Biomedical says co and Celgene entered into side letter\u00a0agreement""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3548197&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHOTuO1glwypFzX8hJgHv2JIEd_ag""",Not Reachable,"""Reuters Key Development"""
"""Mar 13, 2017""","""Agios Pharmaceuticals announces MTAP pathway research program and collaboration agreement with\u00a0Celgene""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3545753&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHVGgEpZVW5Bny9aICG57thHqrS2w""",Not Reachable,"""Reuters Key Development"""
"""Mar 1, 2017""","""Juno Therapeutics reports qtrly net loss per share\u00a0$0.51""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3539114&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHZhBFlvTT1HQ_Z7huUVGQjBtFgTQ""",Not Reachable,"""Reuters Key Development"""
"""Feb 22, 2017""","""FDA expands indication for Revlimid in multiple myeloma patients following\u00a0auto-HSCT""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3533149&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNE6nrTafZRNtfp0GDCVaI9cWqoJWg""",Not Reachable,"""Reuters Key Development"""
"""Feb 17, 2017""","""Celgene reports positive results from Phase III sunbeam trial of oral ozanimod in patients with relapsing multiple\u00a0sclerosis""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3530368&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFPe0wZ159GAkAFWiKST-Nd6tOIjg""",Not Reachable,"""Reuters Key Development"""
"""Feb 10, 2017""","""Celgene receives second subpoena relating to past inquiry - SEC\u00a0filing""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3524986&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEx5K7mjSBnBhcAZu0pewhDXSydiQ""",Not Reachable,"""Reuters Key Development"""
"""Jan 27, 2017""","""Celgene receives positive CHMP opinion to expand REVLIMID\u00a0indication""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3516661&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNH2VbNDBtK-TVc1p_Kl_PTP4v2rvw""",Not Reachable,"""Reuters Key Development"""
"""Jan 26, 2017""","""Celgene CEO says tax reform could provide significant benefit to U.S. economy, healthcare industry - Conf\u00a0Call""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3515981&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEmUSrJyQu_FHF4QqrIo9pvvyGaKg""",Not Reachable,"""Reuters Key Development"""
"""Jan 26, 2017""","""Celgene reports earnings per share\u00a0$0.53""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3515848&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEv9AAzlwH5w1Dwq6cTknM10ThxHw""",Not Reachable,"""Reuters Key Development"""
"""Jan 12, 2017""","""Medidata Solutions says Celgene increased adoption of Medidata Clinical\u00a0Cloud""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3507788&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNH6XtqCj1ZvOEqsyL70oNF1_z1-wg""",Not Reachable,"""Reuters Key Development"""
"""Jan 9, 2017""","""Celgene updates 2017, long-term\u00a0outlook""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3505917&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHzVZM-Rc4pSxcOa8P6sfD-644JDA""",Not Reachable,"""Reuters Key Development"""
"""Dec 19, 2016""","""Versant Ventures announces milestone with Northern Biologics and Bluerock\u00a0Therapeutics""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3497354&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFiSaankcEOTtPqSHYLJDOGecY-TQ""",Not Reachable,"""Reuters Key Development"""
"""Dec 6, 2016""","""Celgene Reports Results of Two Studies for Revlimid in\u00a0Myeloma""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3490917&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGTkdywQ_JDD-FH99ntMPBB68q9Fg""",Not Reachable,"""Reuters Key Development"""
"""Dec 2, 2016""","""Acetylon Pharmaceuticals entered into an agreement to be acquired by Celgene\u00a0Corporation""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3489360&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGg3G2SYz3YAq-eMZcpeiBTwZSNUw""",Not Reachable,"""Reuters Key Development"""
"""Nov 29, 2016""","""Celgene enters into service and license arrangement for GNS Healthcare's causal machine learning\u00a0platform""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3486684&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGtyPD_JqxuEtPBrM08kxfq3-O4GQ""",Not Reachable,"""Reuters Key Development"""
"""Nov 21, 2016""","""MaRS Innovation announces acquisition of first compound from Triphase by\u00a0Celgene""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3482226&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGLlejeNC6r_mablbD_Ead8Q5MK3g""",Not Reachable,"""Reuters Key Development"""
"""Nov 18, 2016""","""PharmAkea extends collaboration with\u00a0Celgene""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3481483&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEFgyEDOAblCwjg0aQJS8uNzHqj8w""",Not Reachable,"""Reuters Key Development"""
"""Nov 18, 2016""","""Triphase Accelerator says Celgene will buy co's assets related to\u00a0marizomib""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3481111&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHn2yMPb3Dq439c14Ma4LeJWVQ1sA""",Not Reachable,"""Reuters Key Development"""
"""Nov 1, 2016""","""Celgene and IBM Watson Health collaborate to transform patient safety\u00a0monitoring""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3467179&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGzXf1DIfr_J3zznOAgkkc06SCoxA""",Not Reachable,"""Reuters Key Development"""
"""Oct 31, 2016""","""Celgene Corp reports 12.3 pct stake in CRISPR Therapeutics AG - SEC\u00a0filing""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3466265&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFHg0QRy_-wPBJkbow41ywgfZTv3w""",Not Reachable,"""Reuters Key Development"""
"""Oct 27, 2016""","""Celgene files for potential mixed shelf\u00a0offering""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3463562&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNG0hSR2V1ygd7Wu5I3iF2OM_fGFuQ""",Not Reachable,"""Reuters Key Development"""
"""Oct 27, 2016""","""Celgene says Q3 growth rate mainly volume driven - conf\u00a0call""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3463256&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFUv-G9KayOzg4ccnN8ot9yf1D3Aw""",Not Reachable,"""Reuters Key Development"""
"""Oct 27, 2016""","""Celgene Q3 adjusted earnings per share\u00a0$1.58""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3462988&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNHR2C1K0GZYuQ9_CwkT3-NJSqQwVw""",Not Reachable,"""Reuters Key Development"""
"""Oct 12, 2016""","""Celgene & Agios collaborates with Abbott to develop diagnostic tests for\u00a0leukemia""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3452628&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFE_TgrcCkJnYwxxNkJg5uB9dDXVw""",Not Reachable,"""Reuters Key Development"""
"""Sep 7, 2016""","""Sutro Biopharma receives 2 milestone payments from\u00a0Celgene""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3438361&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNFN_PKYcAMVX3tUg8yPrF-1PS4xRw""",Not Reachable,"""Reuters Key Development"""
"""Sep 7, 2016""","""Agios Pharma says Celgene expects to submit NDA to U.S. FDA for\u00a0enasidenib""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3438287&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEw4cbPRkTZlPMO4AajG3wBVSsjnQ""",Not Reachable,"""Reuters Key Development"""
"""Aug 24, 2016""","""Celgene reports 8.1 pct passive stake in Oncomed\u00a0Pharmaceuticals""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3431535&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEDQRT3KvHJKq_zPEWmLSu9f8pcLg""",Not Reachable,"""Reuters Key Development"""
"""Jul 28, 2016""","""Celgene reports Q2 GAAP earnings per share\u00a0$0.75""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3413898&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNEsy00KRX-j7incrxmUiRLVK3VdwQ""",Not Reachable,"""Reuters Key Development"""
"""Jul 25, 2016""","""Celgene and LYSARC provide update on the phase III\u00a0study""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3410945&ei=SbAfWpj0KsS6jAHwso7gBA&usg=AFQjCNGy1tOdfYEW-DTa7LR-FI617DS9Vg""",Not Reachable,"""Reuters Key Development"""
"""Jul 19, 2016""","""BRIEF-Jounce Therapeutics to collaborate with Celgene to develop immuno-oncology\u00a0therapies""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3407687&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNGo3FrH8wS3SDHH1zcCdDrQmnK0Mw""",Not Reachable,"""Reuters Key Development"""
"""Jul 15, 2016""","""Celgene International says European Commission approved\u00a0Revlimid""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3405781&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNF_hMOL8piV39PslrzssCTz0qbRdQ""",Not Reachable,"""Reuters Key Development"""
"""Jun 15, 2016""","""Celgene announces additional $3 bln share repurchase\u00a0authorization""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3391545&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHOGKxt_jLBFMYIDrVIhQkI6fw9GA""",Not Reachable,"""Reuters Key Development"""
"""Jun 13, 2016""","""Bionor Pharma says possible extension of alliance with\u00a0Celgene""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3390331&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHQhWcr4B22R-SrZGDYWQcbQldMpQ""",Not Reachable,"""Reuters Key Development"""
"""Jun 10, 2016""","""Acceleron, Celgene says data with Luspatercept show increases in hemoglobin\u00a0levels""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3389669&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNE71gm7xEnPj0cGN-Hm2X29lh3GDg""",Not Reachable,"""Reuters Key Development"""
"""Jun 2, 2016""","""Mylan launches generic vidaza\u00a0injection""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3385935&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNFfgbKlUU_yMrQewYiIediJXAjgZA""",Not Reachable,"""Reuters Key Development"""
"""May 24, 2016""","""TriNetX enters into collaboration with celgene to advance clinical trial design and research for next-generation\u00a0medicines""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3380808&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNFSsk-QsJ_g4hWz9q21vTe67EJHkA""",Not Reachable,"""Reuters Key Development"""
"""May 17, 2016""","""Agios Pharmaceuticals, Celgene establish new collaboration in metabolic\u00a0immuno-oncology""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3377082&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHW_C2aWsrTCdU2uXTjBO9VWhzTRg""",Not Reachable,"""Reuters Key Development"""
"""Feb 11, 2016""","""Celgene Corp appoints Mark Alles CEO, effective March 1,\u00a02016""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3330843&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHWk8SjrZcLXoX1bZ8lWok9fCXjZg""",Not Reachable,"""Reuters Key Development"""
"""Feb 10, 2016""","""Celgene Corp expands eight-year technology relationship with Medidata Solutions\u00a0Inc""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3330310&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNFTMpIhCQK9iG8s7SDglY2GHJV6_Q""",Not Reachable,"""Reuters Key Development"""
"""Jan 11, 2016""","""Celgene Corp announces leadership\u00a0changes""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3319276&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHJ9BNY-HDO5B3ZJ70u56-kyULJSg""",Not Reachable,"""Reuters Key Development"""
"""Dec 10, 2015""","""Inception IBD Inc and Celgene Corp enter strategic collaboration to advance novel therapeutics for inflammatory bowel\u00a0disease""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3309473&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHx1HQB0IgFnYsWLTLLbsCfowTG0Q""",Not Reachable,"""Reuters Key Development"""
"""Dec 7, 2015""","""Celgene in Collaboration with Astrazeneca Announce Initiation of Fusion Clinical Development Program in\u00a0Immuno-Oncology""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3307880&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNFkRcmocGwt3fJNBS-0XIthXilByw""",Not Reachable,"""Reuters Key Development"""
"""Dec 7, 2015""","""Celgene Corporation and Acceleron Pharma Inc announces FDA granted Fast Track Designation to luspatercept for treatment of\u00a0anemia""","""//www.google.com/url?source=finance&q=http%3A%2F%2Fwww.reuters.com%2Ffinance%2Fstocks%2FCELG.O%2Fkey-developments%2Farticle%2F3307866&ei=TLAfWtG4HI3kjAHx2JK4Cg&usg=AFQjCNHXC8ZknKiz1ygmZqmPAvJLwKqZ7w""",Not Reachable,"""Reuters Key Development"""
